Showing posts with label nausea. Show all posts
Showing posts with label nausea. Show all posts

Friday, June 19, 2020

129 CMAAO CORONA FACTS and MYTH BUSTER GI symptoms


129 CMAAO CORONA FACTS and MYTH BUSTER GI symptoms


Dr K K Aggarwal
President CMAAO

With inputs from Dr Monica vasudev

951: Four in 10 Patients with Coronavirus Infection Shed Virus in Stool

Reuters excerpt: 12% of COVID 19 patients experience gastrointestinal symptoms [diarrhea, nausea and vomiting]

40.5% have viral RNA in their stool.

In a meta-analysis of 29 studies that included more than 4,800 patients, researchers found that gastrointestinal symptoms are common and fecal shedding may present an important transmission risk, according to the report published in JAMA Network Open.

At present it's not known if the virus detected in patients' stool samples is infectious.

But if it is, a lot of exposure could happen through a fecal oral route through food handling or in public restrooms - if you were to use a restroom after someone who was pre-symptomatic or asymptomatic, you could potentially contract the virus (if it becomes aerosolized).

Researchers included 23 published studies and six preprint articles, which contained data on a total of 4,805 patients with a mean age of 52.2 years.

Based on pooled data, the researchers found that 12% of patients showed any GI symptoms, with 7.4% reporting diarrhea and 4.6% reporting nausea or vomiting.

Eight of the studies reported on fecal testing for the virus in a total of 407 patients. Viral RNA was detected in feces in 40.5% of the patients. Under electron microscopy, two stool samples (1.3%) showed live virus.

Overall, viral loads in stool samples were lower than in respiratory samples (range, 550 copies per mL to 1.21 × 105 copies per mL versus 641 copies per mL to 1.34 × 1011 copies per mL).

"It's a basic science question: is the virus coming out infectious? Will it survive the acidity of the stomach and infect the intestines?"

Unlike the norovirus, say, SARS-CoV-2 has an envelope of lipid covering it. That lipid layer makes the virus more susceptible to stomach acid.

SOURCE: https://bit.ly/3hp8UDZ JAMA Network Open, online June 11, 2020.



Monday, April 29, 2019

Belimumab, the first drug for lupus in children


The US Food and Drug Administration today approved belimumab (Benlysta) as intravenous (IV) infusion for treatment of children aged 5 years and older with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy.

Belimumab, a human monoclonal antibody, is a B-lymphocyte stimulator (BLyS)-specific inhibitor.

While belimumab is approved for use in adults with SLE, this is the first time that it has been approved for use in children with SLE.

In Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy (PLUTO) of children with SLE, belimumab IV + standard therapy reduced the risk of the patients experiencing a severe flare by 62% and also increased the duration of experiencing the first severe flare, from 82 days to 160 days.

The safety and pharmacokinetic profiles of the drug in pediatric patients were consistent with those in adults with SLE.

Side effects: Nausea, diarrhea and fever

Warning and precautions:  Mortality, serious infections, hypersensitivity and depression; it should not be co-administered with live vaccines. Patients also commonly experienced infusion reactions, so healthcare professionals are advised to pre-treat patients with an antihistamine.

(Source: US FDA)

Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA


Saturday, February 16, 2013

Ask Dr KK:I am having flu like symptoms with nausea and pain in abdomen


I am having flu like symptoms with nausea and pain in abdomen. Is it swine fly?
A: Human flu will not have nausea, diarrhea or pain in abdomen